After reporting robust results, Resmed reckons it won't be subject to US tariffs while the growth of anti-obesity drugs will ...

SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD ... to 10 nights of sleep data for a single patient, capturing night-to-night variability and providing clinicians with a ...

ResMed launched NightOwl™, a home sleep apnea test that enhances user convenience with a small fingertip sensor and cloud data evaluation. Despite the broader market reacting negatively to new ...

Resmed (RMD) announced its home sleep apnea ... records up to 10 nights of sleep data for a single patient, capturing night-to-night variability and providing clinicians with a comprehensive ...

(RTTNews) - ResMed Inc.(RMD), announced Thursday that ... up to 10 nights of sleep data for a single patient, capturing night-to-night variability and providing clinicians with a comprehensive ...

Nunez, M.D., Chief Medical Officer at Resmed.“With NightOwl ... up to 10 nights of sleep data for a single patient, capturing night-to-night variability and providing clinicians with a ...

ResMed launched NightOwl™, a home sleep apnea test that enhances user convenience with a small fingertip sensor and cloud data evaluation. Despite the broader market reacting negatively to new tariffs ...

It also simplifies the process for providers. This is a meaningful step forward in Resmed's mission to deliver life-changing health technology that people love.” NightOwl is a disposable HSAT device ...